Antineoplaston Therapy in Treating Patients With Cancer of Unknown Primary Origin

Clinical trial NCT00003526 · TERMINATED

Trial details

NCT number: NCT00003526
Sponsor: Burzynski Research Institute
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Unknown Primary Carcinoma

Start date: 1996-03-18
Primary completion: 2005-02-02
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.